Clinical trial
A Randomized, Double-Blind, Vehicle-Controlled, Phase 2 Trial to Evaluate the Anti-pruritic Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN008 in Adults With Mild to Moderate Atopic Dermatitis
NCT05870865 is registered in ClinicalTrials.gov with Formation Bio, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Vehicle-Controlled, Phase 2 Trial to Evaluate the Anti-pruritic Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN008 in Adults With Mild to Moderate Atopic Dermatitis
- Lead sponsor
- Formation Bio, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 3, 2023
- Completion date
- December 28, 2023
- Enrollment
- 144 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.